Get your free MedServ E-mail account. At the annual congress of the European Society of Cardiology in Barcelona, Dr. John Cleland, professor of cardiology at the University of Hull, Kingston upon Hull, England, studied 279 patients with moderate heart failure. About 4.7 million people in the United States suffer heart failure, a condition marked by deteriorating ability of the heart to pump normally.
Patients suffer shortness of breath, fatigue and an accumulation of fluids in the body.
The patients are at high risk for heart attack, stroke and sudden death. About a third of patients in the study were on aspirin, a third on the blood thinner warfarin and a third were not receiving any treatment designed to prevent blood clots that could result in heart attacks or strokes. Both aspirin and warfarin are prescribed to prevent these adverse events. Aspirin works in heart attacks. It would be wrong to say that aspirin in rubbish.